index - Plateforme d’immortalisation MyoLine – CRM Accéder directement au contenu

Dernières publications

Chiffres clés

47 Publications avec texte intégral

Open Access

86 %

Mots clés

CDNA synthesis MT RNA/DNA Editing Myotube Mitochondrial ROS Exon skipping Skeletal muscle Mdx52 mice Flavonoid Glucocorticoid-induced muscle atrophy Canine X-linked muscular dystrophy in Japan CXMD J CXCR4 Adeno-associated viral vector Alternative splicing CFTR correctors FSHD Microarray Developmental biology DM1 myoblasts Conjugation KLF15 CLS Myotonic dystrophy Motor neuron Becker muscular dystrophy Lamin A/C nuclei Computer software Gene therapy Fibroblast DNM2 Exon-skipping Gel electrophoresis Mdx Expanded repeats Insulin Duchenne muscular dystrophy CTG⋅CAGn repeat DMD Migration Dominant centronuclear myopathy HDMD/Dmd-null mice Dystrophin Antisense morpholino Acetylcholine receptor subunit epsilon Bile acid Myogenesis BMD Mechanisms of disease Cell biology Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS LRP4 Allele-specific silencing Immortalized dystrophic canine myoblast Autophagosome Actin Human artificial chromosomes Chromatin Endocytosis Folding-defective proteins Eteplirsen Lamina-associated domain Autophagy RNA interference Coculture Fibrosis Atrial cardiac defects Muscle LTβR FoxO Human muscle stem/progenitor cells Dynamin 2 Gene network analysis Glucose Neuromuscular junction CXCL12 Adhesion Machine learning Clinical trial candidate screening MSCs Emerin Laminographie Drisapersen Gut microbiota ITSN1 3D co-culture Mechano-transduction Differentiation CRISPR/Cas9 Centronuclear myopathy DsDNA break repair Immortalisation Human Allele-specific silencing therapy Antisense oligonucleotide Cell-penetrating peptide Lymphotoxin-β-receptor CMS Fear response Exondys 51 ICU-acquired weakness BAF